Clinical trials
Vision Disorders trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 4 |
| Unknown status | 3 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 8 |
| Kodiak Sciences Inc | 3 |
| Amore Filippo | 2 |
| Bayer | 2 |
| Istituto Italiano di Tecnologia | 2 |
| ProQR Therapeutics | 2 |
| ASST Fatebenefratelli Sacco | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| IRCCS National Neurological Institute "C. Mondino" Foundation | 1 |
| Laboratoires Thea | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vision Disorders | 27 |
| Blindness | 8 |
| Retinal Diseases | 8 |
| Eye Diseases | 7 |
| Macular Edema | 7 |
| Retinal Degeneration | 5 |
| Choroidal Neovascularization | 4 |
| Macular Degeneration | 4 |
| Retinal Vein Occlusion | 4 |
| Wet Macular Degeneration | 4 |
Trials
Showing 76 to 27 of 27. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.